Background
Induced sputum is a method to assess airway inflammation in clinical trials for asthma and COPD. [1] [2] [3] Sputum is a heterogeneous, viscous material containing inflammatory cell plugs, cellular debris, mucus, and saliva with squamous cells.
The quality of sputum cell preparations for differential cell count analysis depends on multiple factors and can be highly variable. 4, 5 Percentage of squamous cell contamination (SQ%) is often used to assess the quality of sputum cell preparations. 6 Here, we evaluated a comprehensive quality score, 7 which also includes an assessment of the inflammatory cell morphology and amount of cellular debris.
Methods
A total of 30 sputum cell preparations from healthy subjects and patients with asthma or COPD were selected for a range of sample quality from studies from three German Center for Lung Research (DZL) sputum laboratories. The studies were approved by the respective ethics committees of University of Luebeck (AZ12-215), Marburg (AZ200/09), Munich (AZ5534/12), and Hannover (AZ5963), and written informed consent was obtained from all subjects. Sputum plugs were selected from saliva and processed with dithiothreitol as described. 8 Nine experienced evaluators, blinded to the results of the others, counted 400 cells per sample and rated slide quality using a 5-point scale (0, 0.5, 1, 1.5, 2 -low to high; Figure 1 ). This scale considers cell morphology, amount of cellular debris, and SQ% only if it influences inflammatory cell identification. Interobserver variability (SD) and intraclass correlation coefficients (evaluators vs overall mean cell percentages) were computed. The data set was split into three quality levels based on the mean slide score (low: ,0.75, intermediate: 0.75-1.25, high: .1.25).
Results
A total of 13 sputum cell preparations were rated as low quality, eight as intermediate quality, and nine as high quality. Five slides of a low quality had missing data for two to five evaluators and were excluded from the analysis. The overall mean (range) quality score was 1.1 (0.4-1.6) with a mean SQ% of 12% (1%-42%). Although the results were significant for each evaluator, we observed a correlation between slide quality score and SQ%, with a wide range of r-values (-0.39-0.69). The 17 slides of intermediate quality and high quality had a maximum SQ% of 22%, whereas four of eight slides from the low-quality group had ,22% squamous cells. Interobserver 
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Rating sputum cell quality in clinical trials for asthma and COPD treatment variability for alveolar macrophages (AMs) and neutrophil granulocytes (NGs) did not correlate with SQ% but did significantly correlate with the comprehensive quality score (Figure 2 ). For the samples with high quality and intermediate quality, the mean intraclass correlation coefficient for AM and NG was 0.97 and 0.98, respectively, and for the samples with low quality, it was 0.77 and 0.80, respectively.
Discussion
A proper selection of sputum plugs is important for obtaining high-quality sputum cell preparations. Nevertheless, we showed that the accuracy of differential cell counts also depends on inflammatory cell integrity and amount of cellular debris -criteria that are largely independent of SQ%. We agree with Sohani et al 4 who suggested that sputum samples should not be excluded just for having a higher SQ%.
We focused on AM and NG only, because the number of samples with eosinophils was very low. Although eosinophils are more easily recognized in low-quality samples owing to their distinct staining, their percentages depend on a valid evaluation of AM and NG. In addition, a valid neutrophil count is important to estimate the inflammatory phenotype. 
Conclusion
To judge sputum cell quality adequately and to define potential cutoffs for exclusion of sputum samples in clinical studies, we propose using a more comprehensive sputum slide quality score. We have demonstrated that excluding lowquality samples based on this score reduces inter-evaluator variability. The effect of excluding low-quality samples on the variability of biomarkers in sputum supernatants needs to be tested in further studies.
